Browsing Tag
NASDAQ
801 posts
Intel (NASDAQ: INTC) earnings test a turnaround after a 30% retreat
Intel Corporation enters its second-quarter earnings report with stronger server demand, advancing manufacturing technology and a valuation that still demands substantial execution.
Ondas Inc. (Nasdaq: ONDS) targets $525m in 2026 revenue as DZYNE share overhang weighs on the stock
Ondas Inc. has raised its 2026 revenue target to at least $525 million after closing the $875.8 million DZYNE Technologies acquisition and folding it into a new Ondas Sentinel defence division, but the shares have fallen from a June 2026 high near $9.40 into the mid-$6 range as investors work through a 40 million-share resale registration, a further 45 million shares of deferred consideration due in January 2027 and the integration burden of an unusually acquisition-heavy growth model. The next measurable checkpoint is the second-quarter 2026 earnings report expected in mid-August.
Penguin Solutions (Nasdaq: PENG) secures zero-interest capital to expand its AI factory platform
Penguin Solutions secured zero-coupon funding through 2031, but the refinancing also brings immediate share issuance, higher gross debt and new execution demands.
Docebo (DCBO) launches US$70m issuer bid as preliminary Q2 revenue exceeds prior guidance
Docebo plans to cancel as much as 13.8% of its stock through a largely debt-funded issuer bid while raising its 2026 revenue outlook.
Intuitive Surgical (NASDAQ: ISRG) beats on every Q2 metric but stock falls 10% as guidance holds firm
Intuitive Surgical beat Q2 estimates with $2.89B revenue and $2.80 non-GAAP EPS, but ISRG fell ~10% after hours as procedure guidance stayed at 13.5%–15.5%.
WaFd, Inc. (NASDAQ: WAFD) posts $66m profit as margin holds at 2.81%
WaFd delivered another quarter of earnings growth as commercial lending and deposit repricing supported net interest income. Higher provisions, criticized loans and borrowings leave important questions about the durability of that progress.
Aehr Test Systems stock (NASDAQ: AEHR) surges as $100m backlog resets outlook
Aehr Test Systems stock surged after record bookings and a $100.6 million backlog. Examine AI demand, 2027 guidance, valuation and investor risks.
CleanSpark stock (NASDAQ: CLSK) rises 8.8%: Can its big lease deliver?
CleanSpark signed a 20-year infrastructure lease worth an expected US$6.6 billion, but $CLSK surrendered most of its early 22% surge. Financing, construction costs and the 2027 revenue start now become the critical tests.
Biogen stock (NASDAQ: BIIB) falls 8.2%: Can diranersen recover in Phase 3?
Biogen’s diranersen reduced tau and showed its strongest clinical result at the lowest dose, but the Phase 2 study missed its dose-response goal. With $BIIB down 8.2%, July 29 results and the Phase 3 design become the next tests.
SK hynix (NASDAQ: SKHY) rebounds, but is the ADR premium justified?
SK hynix stock has rebounded after its Nasdaq debut, but a large ADR premium raises a crucial valuation question before earnings.